BIOTRONIK Announces FDA Approvable Status For Revolutionary Heart Failure Therapy System

BOSTON--(BUSINESS WIRE)--May 19, 2006--BIOTRONIK today received Approvable status from the United States Food and Drug Administration for the Kronos LV-T Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Corox OTW Coronary Sinus lead. Kronos and Corox complete BIOTRONIK's pioneering Heart Failure Therapy System, which also includes the ScoutPro Lead Delivery System, Galeo guide wire family, and the BIOTRONIK Home Monitoring remote patient management system.

Back to news